Investigational New Drug application approved by the FDA for COVID-19 candidate vaccine, allowing BAT to progress into a Phase I clinical trial in adult volunteers Vaccine candidate created using innovative plant-based technology Vaccines manufactured using BAT’s vaccine platform have the potential to be stable at room temperature which could offer significant advantages Study demonstrates BAT’s […]

The post BAT progresses COVID-19 candidate vaccine into Phase I human clinical trials appeared first on African Media Agency.